The Piedmont Heart Institute is the only provider in Georgia participating in a new study to evaluate the safety and efficacy of an implantable heart attack alert system. Physicians are currently seeking patients who may be eligible to participate in this groundbreaking clinical trial, for which oversight and support is provided by the Piedmont Healthcare Research Institute. The ALERTS Pivotal Study of the AngelMed Guardian System is being conducted by select physicians across the country, including Piedmont Heart Institute. The Guardian System is comprised of an internal implantable device similar in size to a standard pacemaker with a single lead carefully placed into the heart. The system is designed to monitor and track significant changes in the heart’s electrical signals and then alerts patients via an external telemetry device to seek medical attention.To be eligible for the ALERTS study, patients must have had a heart attack or open heart surgery within the past six months and meet other specific criteria; participate in a screening consultation; and, if selected, agree to visit with study researchers at regular intervals following the procedure. For more information on participating in the trial, e-mail firstname.lastname@example.org or call (404) 605-4477. You may also visit www.piedmont.org/hearttrials.
Atlanta Gastroenterology Associates has announced that Dr. Kavita R. Kongara has joined its staff and will specialize in motility disorders. AG has two Atlanta locations: Emory Midtown at 550 Peachtree St., Suite 1600, and Piedmont West at 1800 Howell Mill Road, Suite 600. For more, visit www.atlantagastro.com.